Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Broussonin A Attenuates Type 2 Diabetic Osteoporosis by Reactivating JAK2/STAT3 Signaling to Inhibit Ferroptosis in BMSCs.

Phytotherapy research : PTR·2026

Same author

BCAA metabolism promotes lung cancer tumorigenesis by enhancing cholesterol biosynthesis.

Cell reports·2026

Same author

RstAB activates type 1 fimbriae to promote uropathogenic <i>Escherichia coli</i> bladder invasion.

iScience·2026

Same author

Mechanism Through Which Antioxidant Polysaccharide from <i>Tetrastigma hemsleyanum</i> Protects Against DSS-Induced Ulcerative Colitis: Insights from Multi-Omics.

Molecules (Basel, Switzerland)·2026

Same author

The evolution of liver graft preservation strategies in liver transplantation.

Hepatobiliary surgery and nutrition·2026

Same author

Research progress on the mechanisms and animal models of Ménière's disease.

Genes & diseases·2026

Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026

Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026

Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026

Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026

Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026

Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Primary pancreatic lymphoma.

Guopei Luo¹, Chen Jin, Deliang Fu

¹Pancreatic Disease Institute, Department of General Surgery Huashan Hospital, Fudan University, Shanghai, China.

|July 8, 2009

Summary

This summary is machine-generated.

Diagnosing primary pancreatic lymphoma often requires surgery, as non-operative methods are successful only 30% of the time. Combining surgery with chemotherapy offers the best treatment outcomes for this rare pancreatic disease.

Related Experiment Videos

Last Updated: Jun 21, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Area of Science:

Oncology
Gastroenterology
Pathology

Background:

Primary pancreatic lymphoma (PPL) is a rare non-Hodgkin lymphoma predominantly affecting the pancreas.
PPL presents diagnostic challenges within the spectrum of pancreatic diseases.

Purpose of the Study:

To summarize diagnostic and therapeutic experiences with primary pancreatic lymphoma.
To evaluate the effectiveness of different treatment modalities for PPL.

Main Methods:

Retrospective review of 7 PPL cases at Huashan Hospital over 3 years.
Comprehensive literature review of primary pancreatic lymphoma and pancreatic lymphoma.

Main Results:

Analysis of 164 cases (7 from the series, 157 from literature).
Non-operative diagnosis success rate was only 30%.
Surgery followed by adjuvant chemotherapy showed a higher curative rate than chemotherapy alone.

Conclusions:

Surgical specimen acquisition is crucial for effective PPL diagnosis.
Combined surgical resection and postoperative chemotherapy represent an effective therapeutic strategy for PPL.